18.03.2008 21:47:00

Wall Street Media Presents a Video of Dr. James Bianco, CEO of Cell Therapeutics, Inc. (Nasdaq and MTA: CTIC)

Wall Street Media is presenting an exclusive highlight video from the presentation of Dr. James Bianco, CEO of Cell Therapeutics, Inc. (NASDAQ and MTA: CTIC) from the Invest Northwest(TM) Investor and CEO Forum on Tuesday, March 18, 2008 at the Bell Harbor International Conference Center in Seattle, WA. Headquartered in Seattle, CTI is a biopharmaceutical company committed to developing an integrated portfolio of oncology products aimed at making cancer more treatable. Please visit the following link to view the video: http://wsmco.com/show.aspx?725_Improved_cancer_therapy For additional coverage from the Invest Northwest(TM) Investor and CEO Forum as well as other major investment bank conferences please visit Wall Street Media at: www.wsmco.com Wall Street Media’s coverage includes all major investment bank conferences with more than 20.000 CEO presentations annually as well as interviews with analysts, fund managers, hedge fund managers and market experts. WSM’s Daily Show features highlight clips of these videos as well as the hosts’ stock picks. The WSM portfolio you will see constantly mentioned may be followed free at www.covestor.com Covestor.com aims to de-institutionalize money management to provide a real-trade sharing service that offers self-directed investors the opportunity to compete with, and be rewarded like, professionals. By sharing the work they already do for themselves Covestor builds each of its members an institutional grade track record, and allows them to track the real portfolios of other proven investors for free.
JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.

Nachrichten zu Cell Therapeutics Incmehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Cell Therapeutics Incmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Indizes in diesem Artikel

NASDAQ Comp. 19 478,88 -0,06%